Monthly Archives: April 2007

Celera and LabCorp® Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays

ROCKVILLE, Md. & BURLINGTON, N.C.–LAWFUEL - Law Newswire –Celera (NYSE:CRA), an Applera Corporation business, and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), a national leader in esoteric and oncology testing, today announced that they have signed an agreement granting LabCorp a license to Celera’s breast cancer metastasis and estrogen/progesterone receptor discoveries. The license agreement allows […]

New lung cancer therapies are created

CLEVELAND, April 25: U.S. scientists have developed a method of treating lung cancer tumors that become resistant to anti-cancer drugs.
The researchers at the Ireland Cancer Center of University Hospitals Case Medical Center in Cleveland, led by Dr. Balazs Halmos, previously found lung cancer cells can become resistant to novel targeted agents, such as Tarceva, a […]

Abortion Breast Cancer Study Ignored Latency Issues, Results Disputed

Boston, MA (LifeNews.com) — A new study released earlier this week sought to put a stain on previous research showing that induced abortions result in a rise in the chance of developing breast cancer. However, the study ignored a 2003 report published in the journal BMC Cancer on latency issues.
The new study, published in the […]

Gene Therapies Show Promise in Cancer

Experimental Drug That Targets Tumors at Their Roots Also Shows Signs of Success
By Charlene Laino
April 18, 2007 (Los Angeles) — Researchers are reporting early success using gene-based therapies to combat cancers ranging from those of lung and skin to those of the breast and prostate.
Meanwhile, other scientists say that an experimental drug designed to put […]

Aspirin May Protect Against Cancer

By Sarah Baldauf
Posted 4/18/07
Preliminary research presented this week at the American Association for Cancer Research annual meeting in Los Angeles suggests that controlling inflammation–the same bodily process that can underlie aches and pains–may be important in preventing and treating cancer. When the body suspects attack by a virus or bacteria, for example, the damaged tissue […]

Traditional Indian herbal mix triphala new hope against pancreatic cancer

New Delhi, APRIL 18: One of the most commonly used herbal formulations in India, triphala, has just been shown to have the potential of being a very effective weapon against pancreatic cancer.
Latest findings of a research being carried out at the University of Pittsburgh Cancer Institute have shown that triphala prevented or significantly slowed […]

Congresswoman from South Bay is fighting cancer

South Bay Rep. Juanita Millender-McDonald is taking a leave of absence from Congress for the next four to six weeks to battle cancer, her office announced Wednesday.
Millender-McDonald, a former Carson councilwoman and state assemblywoman who was elected to the House of Representatives in 1996, was absent from the last week of votes before the Easter […]

Cancer Patients at High Risk of Drug Interactions

(HealthDay News) - Because they often take several medications at the same time, cancer patients are at high risk for adverse drug interactions, Canadian researchers report.
These adverse events can result in the inactivation of cancer-fighting drugs and can also cause severe harm or even death, the team reported in the April 18 issue of the […]

New gene therapy for Stage 4 lung cancer

LOS ANGELES April 18 (UPI) — A gene in a lipid nanoparticle that restores lung cancer cells’ ability to program cell death works against advanced lung cancer, a U.S. study says.
A research team from the M.D. Anderson Cancer Center in Houston said it has used a nanoparticle-based therapy to successfully treat 13 patients whose lung […]

Does Cervical Cancer Vaccine Benefit Last?

(WebMD) Two vaccines for preventing cervical cancer, one that is already available and another that is undergoing FDA review, continue to offer nearly 100 percent protection five years following administration,
new research shows.
The findings come at a time when use of the vaccines is being hotly debated, with states grappling with the issue of access to […]